Related Experiment Video
Updated: May 21, 2026
07:02
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Cholinergic pathways and cognition in patients with schizophrenia: a pilot study
Tarek K Rajji1, Tiffany W Chow, Aristotle N Voineskos
1Geriatric Mental Health Program, Centre for Addiction and Mental Health, Toronto, Canada.
Schizophrenia Research
|June 26, 2012
Summary
Schizophrenia patients exhibit executive dysfunction, which is worsened by compromised cholinergic pathways. This suggests a potential subgroup may benefit from treatments that enhance cholinergic neurotransmission.
Area of Science:
- Neuroscience
- Psychiatry
Background:
- Cognitive deficits are a primary characteristic of schizophrenia.
- Cholinergic neurotransmission disruptions are linked to executive dysfunction in both animal models and human studies.
Purpose of the Study:
- To investigate how impaired cholinergic pathways affect executive and non-executive cognitive functions in schizophrenia patients.
Main Methods:
- Assessed 62 schizophrenia patients and 62 controls using clinical and cognitive measures.
- Utilized MRI to evaluate damage in cholinergic pathways.
- Compared executive function, global cognition, and memory between groups.
Main Results:
- A higher proportion of schizophrenia patients (17.7%) showed compromised cholinergic pathways compared to controls (9.7%), though not statistically significant.
- Both schizophrenia patients and controls with compromised cholinergic pathways demonstrated poorer executive function.
- Executive function was significantly more impaired in patients with compromised pathways.
Conclusions:
- Schizophrenia is associated with diminished executive function compared to controls.
- Compromised cholinergic pathways exacerbate executive dysfunction in schizophrenia.
- Findings suggest a potential patient subgroup benefiting from cholinergic enhancement therapies.
Related Concept Videos
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:28Cholinergic Antagonists: Pharmacological Actions
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...